Quality standards for real-world research. Focus on observational database studies of comparative effectiveness (Q45145758)

10 December 2017

Quality standards for real-world research. Focus on observational database studies of comparative effectiveness (English)

1 reference

10 December 2017

0 references

2

1 reference

10 December 2017

Mike Thomas

6

0 references

Alberto A Papi

object named as

Alberto Papi

5

0 references

Nicolas Roche

object named as

Nicolas Roche

1

0 references

Cynthia M Rand

9

object named as

Cynthia Rand

1 reference

10 December 2017

11

David Price

1 reference

10 December 2017

Richard Martin

3

1 reference

10 December 2017

Guy Brusselle

4

1 reference

10 December 2017

Dirjke Postma

7

1 reference

10 December 2017

Vicky Thomas

8

1 reference

10 December 2017

Alison Chisholm

10

1 reference

10 December 2017

Respiratory Effectiveness Group

12

1 reference

10 December 2017

1 February 2014

1 reference

Proceedings of the American Thoracic Society

10 December 2017

1 reference

10 December 2017

11 Suppl 2

1 reference

10 December 2017

S99-104

1 reference

A call for action: Comparative effectiveness research in asthma

10 December 2017

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Influence of body mass index on the response to asthma controller agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Allergic rhinitis: evidence for impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

From randomized controlled trials to observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Integrating real-life studies in the global therapeutic research framework.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Improving the reporting of pragmatic trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

SPIRIT 2013: new guidance for content of clinical trial protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Database studies in asthma pharmacoeconomics: uses, limitations and quality markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Utilization of health care databases for pharmacoepidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database A

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

The Brussels Declaration: the need for change in asthma management

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201309-300RM

10.1513/ANNALSATS.201309-300RM

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference